Showing results (641-650 of 713) with videos related to

Sort By:
Pageof 72
Brain : a Journal of Neurology|April 25, 2015
Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9Maren Lindner, Katja Thümmler, Ariel Arthur, et al.
Nature|March 29, 2019
Author Correction: Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolutionTakahiro Masuda, Roman Sankowski, Ori Staszewski, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
A new structural alert for benzimidazoles: 2,6-dimethylphenyl substituents increase mutagenic potential and time-dependent CYP3A4 inhibition riskYoungshin Kwak, Gary Coppola, Cornelia J Forster, et al.
Nature Medicine|July 24, 2019
GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosisEdoardo Galli, Felix J Hartmann, Bettina Schreiner, et al.
Journal of Cell Science|July 27, 2007
Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous miceLise Sofie Haug Nissen-Meyer, Rune Jemtland, Vigdis T Gautvik, et al.
Nature|February 15, 2019
Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolutionTakahiro Masuda, Roman Sankowski, Ori Staszewski, et al.
International Journal for Parasitology. Drugs and Drug Resistance|June 23, 2018
Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularisReto Rufener, Dominic Ritler, Jana Zielinski, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2025
Native metabolomics identifies pteridines as CutA ligands and modulators of copper bindingBerenike C Wagner, Karoline Steuer-Lodd, Christian Geibel, et al.
The American Journal of Psychiatry|June 1, 2000
Association between bipolar disorder and monoamine oxidase A gene polymorphisms: results of a multicenter studyM Preisig, F Bellivier, B T Fenton, et al.
Frontiers in Immunology|May 10, 2021
Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical RecoveryAurelia Zimmerli, Matteo Monti, Craig Fenwick, et al.
Pageof 72